Ultomiris shows strong interim results in Phase III IgA nephropathy trial

IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys

Samsung Bioepis unveils promising preclinical data for novel ADC SBE303 at AACR 2026

SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers

BioMed X launches AI-driven bispecific antibody research team in France

The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols

NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering

The innovation is particularly suited for bone and cartilage repair

Aurobindo Pharma wins USFDA nod for rare disease drug set for immediate launch

AWS unveils Amazon Bio Discovery to accelerate drug design with AI

Galderma rolls out next-generation regenerating skin nectar

Danone India backs community-led anaemia screening for 1 lakh children in UP

The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner

OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants

New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences